We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $80.4 · 15 analysts
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 06. | After market close (AMC) | $0.06 | — | — | $99.34M | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $-0.14 | — | — | $60.81M | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $-0.44 | — | — | $142.87M | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $-0.28 | — | — | $79.94M | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 22. | Barclays | — | Initiate coverage | — → Overweight | — | Barclays: Overweight |
| 2026. 05. 21. | DA Davidson | — | Maintain | Buy → Buy | — | DA Davidson: Buy |
| 2026. 05. 12. | Morgan Stanley | — | Maintain | Overweight → Overweight | — | Morgan Stanley: Overweight |
| 2026. 05. 08. | Wedbush | — | Maintain | Outperform → Outperform | — | Wedbush: Outperform |
| 2026. 04. 20. | Wedbush | — | Initiate coverage | — → Outperform | — | Wedbush: Outperform |
| 2026. 04. 09. | Morgan Stanley | — | Maintain | Overweight → Overweight | — | Morgan Stanley: Overweight |
As of FY2026Q1 · Source: SEC/DART + price data
No holdings data to show.